β-Lactam antibiotic targets and resistance mechanisms: from covalent inhibitors to substrates

M Mora-Ochomogo, CT Lohans - RSC Medicinal Chemistry, 2021 - pubs.rsc.org
The β-lactams are the most widely used antibacterial agents worldwide. These antibiotics, a
group that includes the penicillins and cephalosporins, are covalent inhibitors that target …

Structure and mechanism-guided design of dual serine/metallo-carbapenemase inhibitors

C Chen, P Oelschlaeger, D Wang, H Xu… - Journal of Medicinal …, 2022 - ACS Publications
Serine/metallo-carbapenemase-coproducing pathogens, often referred to as “superbugs”,
are a significant clinical problem. They hydrolyze nearly all available β-lactam antibiotics …

Discovery of 2-aminothiazole-4-carboxylic acids as broad-spectrum metallo-β-lactamase inhibitors by mimicking carbapenem hydrolysate binding

YH Yan, TT Zhang, R Li, SY Wang, LL Wei… - Journal of Medicinal …, 2023 - ACS Publications
Metallo-β-lactamases (MBLs) are zinc-dependent enzymes capable of hydrolyzing all
bicyclic β-lactam antibiotics, posing a great threat to public health. However, there are …

Zidovudine-β-Lactam Pronucleoside Strategy for Selective Delivery into Gram-Negative Bacteria Triggered by β-Lactamases

M Rosales-Hurtado, F Sannio, L Lari… - ACS Infectious …, 2023 - ACS Publications
Addressing antibacterial resistance is a major concern of the modern world. The
development of new approaches to meet this deadly threat is a critical priority. In this article …

[HTML][HTML] Approachable Synthetic Methodologies for Second-Generation β-Lactamase Inhibitors: A Review

N Fatima, S Khalid, N Rasool, M Imran, B Parveen… - Pharmaceuticals, 2024 - mdpi.com
Some antibiotics that are frequently employed are β-lactams. In light of the hydrolytic
process of β-lactamase, found in Gram-negative bacteria, inhibitors of β-lactamase (BLIs) …

β-lactamase-mediated fragmentation: historical perspectives and recent advances in diagnostics, imaging, and antibacterial design

MS Cole, PV Hegde, CC Aldrich - ACS Infectious Diseases, 2022 - ACS Publications
The discovery of β-lactam (BL) antibiotics in the early 20th century represented a remarkable
advancement in human medicine, allowing for the widespread treatment of infectious …

Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products

P Hinchliffe, K Calvopiña, P Rabe, MF Mojica… - Journal of Biological …, 2023 - ASBMB
L1 is a dizinc subclass B3 metallo-β-lactamase (MBL) that hydrolyzes most β-lactam
antibiotics and is a key resistance determinant in the Gram-negative pathogen …

In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant Enterobacterales

BK Peters, N Reddy, M Shungube… - ACS Infectious …, 2023 - ACS Publications
β-lactams are the most prescribed class of antibiotics due to their potent, broad-spectrum
antimicrobial activities. However, alarming rates of antimicrobial resistance now threaten the …

Rational Design of Benzobisheterocycle Metallo-β-Lactamase Inhibitors: A Tricyclic Scaffold Enhances Potency against Target Enzymes

V Villamil, MA Rossi, MF Mojica… - Journal of Medicinal …, 2024 - ACS Publications
Antimicrobial resistance is a global public health threat. Metallo-β-lactamases (MBLs)
inactivate β-lactam antibiotics, including carbapenems, are disseminating among Gram …

Discovery of YFJ-36: Design, Synthesis, and Antibacterial Activities of Catechol-Conjugated β-Lactams against Gram-Negative Bacteria

F Liu, Q Kou, H Li, Y Cao, M Chen… - Journal of Medicinal …, 2024 - ACS Publications
Cefiderocol is the first approved catechol-conjugated cephalosporin against multidrug-
resistant Gram-negative bacteria, while its application was limited by poor chemical stability …